Have your own idea? Try our Stock Screener
Chinese (SSE) Biotech Industry Analysis
UpdatedSep 26, 2025
DataAggregated Company Financials
Companies71
- 7D-2.0%
- 3M8.1%
- 1Y24.6%
- YTD19.9%
Over the last 7 days, the Biotech industry has dropped 2.0%, driven by Chongqing Zhifei Biological Products declining 5.6%. On the other hand Gan & Lee Pharmaceuticals is actually up 10%. In the past year, the industry has gained 25%. Looking forward, earnings are forecast to grow by 54% annually.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Sep 2025 | CN¥966.5b | CN¥107.5b | CN¥5.0b | 51.1x | 191.7x | 9x |
| Sun, 24 Aug 2025 | CN¥1.0t | CN¥108.6b | CN¥6.7b | 43.9x | 149.7x | 9.2x |
| Tue, 22 Jul 2025 | CN¥949.3b | CN¥112.9b | CN¥8.2b | 41.7x | 115.3x | 8.4x |
| Thu, 19 Jun 2025 | CN¥864.5b | CN¥113.0b | CN¥8.3b | 36.9x | 104.3x | 7.7x |
| Sat, 17 May 2025 | CN¥819.0b | CN¥113.3b | CN¥8.3b | 35.3x | 98.5x | 7.2x |
| Mon, 14 Apr 2025 | CN¥845.8b | CN¥134.2b | CN¥11.5b | 34.9x | 73.4x | 6.3x |
| Wed, 12 Mar 2025 | CN¥866.3b | CN¥136.2b | CN¥11.6b | 32x | 74.9x | 6.4x |
| Fri, 07 Feb 2025 | CN¥813.0b | CN¥136.0b | CN¥10.8b | 32.7x | 75.6x | 6x |
| Sun, 05 Jan 2025 | CN¥801.6b | CN¥136.0b | CN¥10.8b | 32.5x | 74.5x | 5.9x |
| Tue, 03 Dec 2024 | CN¥904.5b | CN¥136.0b | CN¥10.8b | 34.3x | 84.1x | 6.6x |
| Thu, 31 Oct 2024 | CN¥905.0b | CN¥141.8b | CN¥11.3b | 33.8x | 79.8x | 6.4x |
| Sat, 28 Sep 2024 | CN¥853.6b | CN¥154.1b | CN¥14.5b | 36x | 59.1x | 5.5x |
| Mon, 26 Aug 2024 | CN¥765.6b | CN¥161.1b | CN¥17.4b | 27.2x | 44.1x | 4.8x |
| Wed, 24 Jul 2024 | CN¥812.4b | CN¥161.1b | CN¥17.3b | 32.2x | 47x | 5x |
| Fri, 21 Jun 2024 | CN¥851.7b | CN¥161.1b | CN¥17.3b | 32.1x | 49.2x | 5.3x |
| Sun, 19 May 2024 | CN¥952.3b | CN¥161.1b | CN¥17.3b | 39.1x | 55.2x | 5.9x |
| Tue, 16 Apr 2024 | CN¥926.5b | CN¥161.4b | CN¥20.3b | 35.4x | 45.6x | 5.7x |
| Thu, 14 Mar 2024 | CN¥1.0t | CN¥165.5b | CN¥22.1b | 37.5x | 46.6x | 6.2x |
| Sat, 10 Feb 2024 | CN¥955.7b | CN¥167.9b | CN¥21.4b | 31.9x | 44.6x | 5.7x |
| Mon, 08 Jan 2024 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39x | 50.1x | 6.4x |
| Wed, 06 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39.7x | 52.1x | 6.7x |
| Fri, 03 Nov 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39.4x | 50.5x | 6.5x |
| Sun, 01 Oct 2023 | CN¥1.1t | CN¥170.9b | CN¥25.2b | 42.6x | 41.7x | 6.2x |
| Tue, 29 Aug 2023 | CN¥972.4b | CN¥171.4b | CN¥28.4b | 36x | 34.2x | 5.7x |
| Thu, 27 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.9b | 40.3x | 37.1x | 6.3x |
| Sat, 24 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 37.9x | 36.4x | 6x |
| Mon, 22 May 2023 | CN¥1.2t | CN¥177.7b | CN¥29.6b | 41.5x | 39.2x | 6.5x |
| Wed, 19 Apr 2023 | CN¥1.3t | CN¥187.3b | CN¥36.5b | 43.2x | 35.2x | 6.9x |
| Fri, 17 Mar 2023 | CN¥1.2t | CN¥179.2b | CN¥36.1b | 44.4x | 34.4x | 6.9x |
| Sun, 12 Feb 2023 | CN¥1.3t | CN¥179.6b | CN¥37.9b | 43.3x | 34.6x | 7.3x |
| Tue, 10 Jan 2023 | CN¥1.3t | CN¥175.6b | CN¥37.9b | 40x | 33.4x | 7.2x |
| Thu, 08 Dec 2022 | CN¥1.2t | CN¥175.6b | CN¥37.9b | 39.1x | 32.8x | 7.1x |
| Sat, 05 Nov 2022 | CN¥1.3t | CN¥175.9b | CN¥38.1b | 39.2x | 33x | 7.1x |
| Mon, 03 Oct 2022 | CN¥1.1t | CN¥174.3b | CN¥40.2b | 30x | 28.1x | 6.5x |
Price to Earnings Ratio
28.1x
Current Industry PE
- Investors are optimistic on the Chinese Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 192x which is higher than its 3-year average PE of 60.1x.
- The 3-year average PS ratio of 6.5x is lower than the industry's current PS ratio of 9.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 50% per year over the last three years,
- Revenues have also declined 15% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 0.98% | |
| Healthcare | -1.55% | |
| Biotech | -2.02% | |
| Biotech | -2.02% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603087 Gan & Lee Pharmaceuticals | CN¥78.07 | 10.1% +CN¥4.3b | 73.7% | PE50.6x | |
| 688336 Sunshine Guojian Pharmaceutical (Shanghai) | CN¥55.97 | 7.6% +CN¥2.4b | 190.8% | PE45.1x | |
| 688293 Shanghai OPM Biosciences | CN¥66.17 | 23.9% +CN¥1.4b | 122.8% | PE218x | |
| 688278 Xiamen Amoytop Biotech | CN¥82.03 | 3.7% +CN¥1.2b | 29.7% | PE35.1x | |
| 600201 Jinyu Bio-technology | CN¥9.34 | 3.8% +CN¥376.9m | 37.8% | PE222.7x |